Patent 7485776 was granted and assigned to E.I. Du Pont De Nemours And Company on February, 2009 by the United States Patent and Trademark Office.
This invention relates to an isolated nucleic acid fragment encoding a disease resistance factor. The invention also relates to the construction of a chimeric gene encoding all or a substantial portion of the disease resistance factor, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the disease resistance factor in a transformed host cell.